Cardiogenics Magnetic Beads Fact Sheet

Download PDF Version

Summary

CardioGenics’ silver-coated paramagnetic beads (the “CardioGenics Beads”) represent a significant product advance over current similar commercial products. All commercial magnetic beads are made of dark iron oxide. CardioGenics has developed a proprietary process to plate magnetic beads with a layer of silver, making them white, and more sensitive to light. In testing against all commercially available beads, the CardioGenics Beads demonstrated a seven-fold improvement in light harvesting, which results in improved testing sensitivity. 
 
Market Background
► Due to simplicity in use and ease of manipulation, magnetic particles are the preferred solid phase for immobilizing biological material used in test kits developed for:

  • Clinical laboratory testing analyzers (immunoassays/DNA binding)
  • Life sciences research market
  • Cell & nucleic acid separation
  • Protein purification
  • Sample enrichment

Market of Magnetic Beads

  • Global In Vitro Diagnostic (IVD) market estimated at $22.9 billion in 2002
  • Expected growth of the IVD is 7% per year
  • Immunoassay testing segment of this market is 40%
  • About 90% of the immunoassay analyzers employ both magnetic particles and light measurements
  • Estimated magnetic beads market is about $1 billion for immunoassay only (3rd party market report)

Magnetic Beads Producers

  • Several companies commercialize magnetic particles for biomedical research and in-vitro diagnostic applications
  • All commercial products contain dark iron oxide material
  • Current commercial manufacturing processes is by encapsulation of magnetic pigment inserted in a latex particle
  • Three (3) main players, led by Merck Chimie, several small ones
  • Prices range from $900-1500/gram of solids

The CardioGenics Beads

  • A 24 month developmental process supported by grants from National Research Council of Canada (NRC), 4 in total
  • Proprietary silver-plating process, adapted to various sizes (1-50 micron) beads
  • CardioGenics Beads plated with silver for color conversion (Black to White) 
  • CardioGenics Beads are then polymer encapsulated
  • CardioGenics developed its own polymer encapsulation process
  • CardioGenics also produced beads to be encapsulated by its partner through their proprietary polymer encapsulation process
  • CardioGenics encapsulated beads are manufactured by a simplified process
  • Beads encapsulated by CardioGenics will be processed in batch sizes of “commercial lots”

 

Competitive Advantages
► Current commercial beads suffer from the following shortcomings:

  • All commercial magnetic particles are dark
  • About 80% of generated light, is lost which results in low testing sensitivity
  • The manufacturing process is complicated and expensive

The CardioGenics Beads offer the following advantages:

  • Maximize light collection by white color conversion 
  • High magnetic moment, easy manipulation
  • Chemically-robust surface chemistry
  • Simplified manufacturing process-- less costly
  • Compared with beads of all major suppliers, the CardioGenics Beads show consistent ~7 fold improved light signal to address needs of IVD industry for more sensitive tests (published data).

Market Advantage
Applications that would benefit from:

  • Increased test sensitivity by at least ~5 fold, early diagnosis
  • Easy sample manipulation
  • Custom-made linking chemistry

Potential End Users
Clinical In-Vitro Diagnostics test developers

  • Ten (10) first tier global IVD test manufacturers
  • Thirty (30) second tier IVD test manufacturers
  • Numerous small regional manufactures

Life sciences research applications, companies/universities

Future Markets:

  • Proteins/ DNA Binding
  • Cell sorting
  • Nanoreactors
  • Adaptation to POC/other instruments (non-competitive)

Market Data